MKI67 and colorectal cancer: In addition, artesunate depleted the population of highly proliferative Ki67-positive tumor cells in patients with colorectal cancer (Phase 1) [129] and is now in Phase 2 trials in patients with stage II/III colorectal cancer awaiting surgical treatment [130] and cervical high-grade intraepithelial neoplasia [131].